171 related articles for article (PubMed ID: 27941019)
1. Incidence and predictors of sudden death, major conduction defects and sustained ventricular tachyarrhythmias in 1388 patients with myotonic dystrophy type 1.
Wahbi K; Babuty D; Probst V; Wissocque L; Labombarda F; Porcher R; Bécane HM; Lazarus A; Béhin A; Laforêt P; Stojkovic T; Clementy N; Dussauge AP; Gourraud JB; Pereon Y; Lacour A; Chapon F; Milliez P; Klug D; Eymard B; Duboc D
Eur Heart J; 2017 Mar; 38(10):751-758. PubMed ID: 27941019
[TBL] [Abstract][Full Text] [Related]
2. Risk of arrhythmias in myotonic dystrophy: trial design of the RAMYD study.
Dello Russo A; Mangiola F; Della Bella P; Nigro G; Melacini P; Bongiorni MG; Tondo C; Calò L; Messano L; Pace M; Pelargonio G; Casella M; Sanna T; Silvestri G; Modoni A; Zachara E; Moltrasio M; Morandi L; Nigro G; Politano L; Palladino A; Bellocci F
J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):51-8. PubMed ID: 19708226
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of mexiletine effect on conduction delay and bradyarrhythmic complications in patients with myotonic dystrophy type 1 over long-term follow-up.
Vio R; Zorzi A; Bello L; Bozzoni V; Botta A; Rivezzi F; Leoni L; Migliore F; Bertaglia E; Iliceto S; Pegoraro E; Corrado D; Calore C
Heart Rhythm; 2020 Nov; 17(11):1944-1950. PubMed ID: 32525073
[TBL] [Abstract][Full Text] [Related]
4. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1.
Groh WJ; Groh MR; Saha C; Kincaid JC; Simmons Z; Ciafaloni E; Pourmand R; Otten RF; Bhakta D; Nair GV; Marashdeh MM; Zipes DP; Pascuzzi RM
N Engl J Med; 2008 Jun; 358(25):2688-97. PubMed ID: 18565861
[TBL] [Abstract][Full Text] [Related]
5. Association Between Mutation Size and Cardiac Involvement in Myotonic Dystrophy Type 1: An Analysis of the DM1-Heart Registry.
Chong-Nguyen C; Wahbi K; Algalarrondo V; Bécane HM; Radvanyi-Hoffman H; Arnaud P; Furling D; Lazarus A; Bassez G; Béhin A; Fayssoil A; Laforêt P; Stojkovic T; Eymard B; Duboc D
Circ Cardiovasc Genet; 2017 Jun; 10(3):. PubMed ID: 28611030
[TBL] [Abstract][Full Text] [Related]
6. Arrhythmic CArdiac DEath in MYotonic dystrophy type 1 patients (ACADEMY 1) study: the predictive role of programmed ventricular stimulation.
Russo V; Papa AA; Rago A; Ciardiello C; Martino AM; Stazi A; Golino P; Calò L; Nigro G
Europace; 2022 Jul; 24(7):1148-1155. PubMed ID: 35861549
[TBL] [Abstract][Full Text] [Related]
7. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease.
Wahbi K; Meune C; Porcher R; Bécane HM; Lazarus A; Laforêt P; Stojkovic T; Béhin A; Radvanyi-Hoffmann H; Eymard B; Duboc D
JAMA; 2012 Mar; 307(12):1292-301. PubMed ID: 22453570
[TBL] [Abstract][Full Text] [Related]
9. QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy.
Debonnaire P; Katsanos S; Joyce E; VAN DEN Brink OV; Atsma DE; Schalij MJ; Bax JJ; Delgado V; Marsan NA
J Cardiovasc Electrophysiol; 2015 May; 26(5):547-55. PubMed ID: 25648421
[TBL] [Abstract][Full Text] [Related]
10. Cardiac Conduction Disorders as Markers of Cardiac Events in Myotonic Dystrophy Type 1.
Itoh H; Hisamatsu T; Tamura T; Segawa K; Takahashi T; Takada H; Kuru S; Wada C; Suzuki M; Suwazono S; Sasaki S; Okumura K; Horie M; Takahashi MP; Matumura T
J Am Heart Assoc; 2020 Sep; 9(17):e015709. PubMed ID: 32812471
[TBL] [Abstract][Full Text] [Related]
11. Twenty-four-hour ambulatory ECG monitoring relevancy in myotonic dystrophy type 1 follow-up: Prognostic value and heart rate variability evolution.
Gamet A; Degand B; Le Gal F; Bidegain N; Delaubier A; Gilbert-Dussardier B; Christiaens L; Garcia R
Ann Noninvasive Electrocardiol; 2019 Jan; 24(1):e12587. PubMed ID: 30101452
[TBL] [Abstract][Full Text] [Related]
12. Pacemaker and implantable cardioverter-defibrillator use in a US myotonic dystrophy type 1 population.
Bhakta D; Shen C; Kron J; Epstein AE; Pascuzzi RM; Groh WJ
J Cardiovasc Electrophysiol; 2011 Dec; 22(12):1369-75. PubMed ID: 22035077
[TBL] [Abstract][Full Text] [Related]
13. Long-term arrhythmia follow-up of patients with myotonic dystrophy.
Benhayon D; Lugo R; Patel R; Carballeira L; Elman L; Cooper JM
J Cardiovasc Electrophysiol; 2015 Mar; 26(3):305-10. PubMed ID: 25546341
[TBL] [Abstract][Full Text] [Related]
14. Optical Mapping Approaches on Muscleblind-Like Compound Knockout Mice for Understanding Mechanistic Insights Into Ventricular Arrhythmias in Myotonic Dystrophy.
Chou CC; Chang PC; Wei YC; Lee KY
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28416514
[TBL] [Abstract][Full Text] [Related]
15. Myotonic dystrophy type 1 and high ventricular vulnerability at the electrophysiological evaluation: ICD yes or not?
Sirico G; Montisci A; Secchi F; Mantica M
Acta Myol; 2020 Mar; 39(1):32-35. PubMed ID: 32607478
[TBL] [Abstract][Full Text] [Related]
16. Severe cardiac arrhythmias in young patients with myotonic dystrophy type 1.
Bassez G; Lazarus A; Desguerre I; Varin J; Laforêt P; Bécane HM; Meune C; Arne-Bes MC; Ounnoughene Z; Radvanyi H; Eymard B; Duboc D
Neurology; 2004 Nov; 63(10):1939-41. PubMed ID: 15557517
[TBL] [Abstract][Full Text] [Related]
17. Predictors of atrio-ventricular conduction disease, long-term outcomes in patients with myotonic dystrophy types I and II.
Ha AH; Tarnopolsky MA; Bergstra TG; Nair GM; Al-Qubbany A; Healey JS
Pacing Clin Electrophysiol; 2012 Oct; 35(10):1262-9. PubMed ID: 22385162
[TBL] [Abstract][Full Text] [Related]
18. Malignant cardiac involvement in a family with myotonic dystrophy.
Melillo G; Ruggieri MP; Magni G; Fragola PV; Antonini G; Vichi R; Cannata D; Fenici RR
G Ital Cardiol; 1996 Aug; 26(8):853-61. PubMed ID: 8962420
[TBL] [Abstract][Full Text] [Related]
19. The heart and cardiac pacing in Steinert disease.
Nigro G; Papa AA; Politano L
Acta Myol; 2012 Oct; 31(2):110-6. PubMed ID: 23097601
[TBL] [Abstract][Full Text] [Related]
20. Supraventricular and Ventricular Arrhythmias Are Related to the Type of Myotonic Dystrophy but Not to Disease Duration or Neurological Status.
Bienias P; Łusakowska A; Ciurzyński M; Rymarczyk Z; Irzyk K; Kurnicka K; Kamińska A; Pruszczyk P
Pacing Clin Electrophysiol; 2016 Sep; 39(9):959-68. PubMed ID: 27444982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
